<DOC>
	<DOCNO>NCT02492698</DOCNO>
	<brief_summary>The objective evaluate effect consumption dual probiotic strain contain Lactobacillus curvatus ( L. curvatus ) HY7601 Lactobacillus plantarum ( L. plantarum ) KY1032 weight loss , body adiposity inflammatory marker include lipoprotein-associated phospholipase A2 ( Lp-PLA2 ) activity overweight subject .</brief_summary>
	<brief_title>Changes Body Adiposity Dual Probiotic Strains Positively Correlated With Changes Lp-PLA2 Activity Overweight Adults</brief_title>
	<detailed_description>A randomized , double-blind , placebo-controlled study conduct 120 subject age 20 65 year , nondiabetic ( fast blood glucose &lt; 126 mg/dL 2-hour blood glucose &lt; 200 mg/dL ) , overweight ( 25 kg/m2 ≤ body mass index ( BMI ) &lt; 30 kg/m2 ) . Over 12 week test period , probiotic group consume 2 g powder twice day contain L. curvatus HY7601 L. plantarum KY1032 , placebo group consume product without probiotic 12 week .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<criteria>Age 20 65 year Nondiabetic ( fast blood glucose &lt; 126 mg/dL 2hour blood glucose &lt; 200 mg/dL ) Overweight ( 25 kg/m2 ≤ body mass index ( BMI ) &lt; 30 kg/m2 ) Constant consumption probiotic product within 1 month screen Unstable body weight ( body weight change &gt; 1 kg within 3 month screen ) Hypertension Type 2 diabetes Cardiovascular disease Cerebrovascular disease Thyroid disease Dietary supplementation within 6 month screen Pregnancy breastfeed Medication affect body weight , energy expenditure , glucose control antibiotic treatment within 3 month screen Acute chronic infection Liver disease Kidney disease Gastrointestinal disease Cancer Medication alcohol abuse Any acute chronic disease require treatment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Probiotic</keyword>
	<keyword>Weight loss</keyword>
	<keyword>Lp-PLA2</keyword>
</DOC>